Medical Xpress·5 min read·hard
Experimental vaccine for 'neglected disease' carried by hundreds of millions of people shows promising results
T
Texas Tech University
✦AI Summary
Researchers at Texas Tech University have developed an experimental vaccine called SchistoShield that shows promise in treating schistosomiasis. The vaccine successfully triggers an immune response and memory, potentially helping the 250 million people currently infected.
Why it matters
Schistosomiasis is a major neglected tropical disease, and an effective vaccine could significantly improve public health in developing nations.
edited by Gaby Clark , reviewed by Robert Egan
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The article is based on scientific research and medical reporting standards.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in